Currently, yes semaglutide has proven cardiovascular benefit from the SELECT trial (2023), which demonstrated significant reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in patients with obesity and established heart disease
If you have a history of arrhythmias, heart failure, coronary artery disease, or other cardiac conditions, report any new or worsening cardiovascular symptoms promptly
The clinical signal matches the biology
Always follow your healthcare providers instructions and recommendations while using semaglutide
However, if you eat more calories per day or if you do muscle-building workouts, you may need more protein each day